PDR001 Plus Imatinib for Metastatic or Unresectable GIST

NCT03609424 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

39

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Stromal Tumors

Interventions

DRUG: PDR001, Imatinib

Sponsor

Asan Medical Center

Collaborators

[object Object]